Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Vascularisation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01831947
What this trial is testing

Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.

Who this might be right for
Macular Degeneration
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40
Not applicableUnknownNCT04686110
What this trial is testing

Analysis of Capillary Retinal and Papillary Vascularization in Patients With Amyotrophic Lateral Sclerosis - CAPISLA

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Angers 94
Not applicableStudy completedNCT01833325
What this trial is testing

Proton Radiation Therapy for Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Florida 9
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Post-approval studies (Phase 4)Study completedNCT01810042
What this trial is testing

Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

Who this might be right for
Exudative Age-related Macular Degeneration
Pusan National University Hospital 49
Testing effectiveness (Phase 2)Ended earlyNCT00395057
What this trial is testing

A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration

Who this might be right for
Choroid NeovascularizationAge-Related Macular Degeneration
Allergan 138
Testing effectiveness (Phase 2)Study completedNCT04290195
What this trial is testing

Use of Ziv Aflibercept in Different Retinal Diseases

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
Amin El Sayed Nawar 55
Testing effectiveness (Phase 2)WithdrawnNCT01015495
What this trial is testing

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Who this might be right for
Angioid Streaks
University of Illinois at Chicago
Large-scale testing (Phase 3)Study completedNCT02034006
What this trial is testing

The Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

Who this might be right for
Choroidal Neovascularization Secondary to Pathologic Myopia
Novartis Pharmaceuticals 200
Not applicableWithdrawnNCT00618644
What this trial is testing

Ranibizumab for Neovascularization in Sickle Cell Retinopathy

Who this might be right for
Sickle Cell AnemiaRetinopathy
Kresge Eye Institute
Not applicableStudy completedNCT01846351
What this trial is testing

Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes

Who this might be right for
Epiretinal MembraneAge Related Macular Degeneration
New England Retina Associates 16
Not applicableStudy completedNCT00358345
What this trial is testing

PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 347
Post-approval studies (Phase 4)Ended earlyNCT00327470
What this trial is testing

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD

Who this might be right for
Age Related Macular Degeneration (AMD)Macular DegenerationChoroidal Neovascularization (CNV)
Pfizer 288
Testing effectiveness (Phase 2)Active Not RecruitingNCT05536973
What this trial is testing

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Who this might be right for
Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 69
Post-approval studies (Phase 4)Study completedNCT01580020
What this trial is testing

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 175
Not applicableActive Not RecruitingNCT06125977
What this trial is testing

Impact of Non-Exudative Type 1 MNV on AMD Progression

Who this might be right for
Age-Related Macular DegenerationNeovascularization, Choroidal
University of Utah 73
Not applicableEnded earlyNCT04855123
What this trial is testing

Evaluation of the Degradation of Renal Function Post Nephrectomy According to Retinal Vascularisation Parameters

Who this might be right for
NephrostomyRetinal Vascularisation
Centre Hospitalier Universitaire Dijon 30
Testing effectiveness (Phase 2)Study completedNCT00729846
What this trial is testing

Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)

Who this might be right for
Age Related Macular DegenerationChoroidal NeovascularizationMacular Edema
California Retina Consultants 22
Not applicableUnknownNCT04245072
What this trial is testing

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

Who this might be right for
Chorioretinitis
The Filatov Institute of Eye Diseases and Tissue Therapy 100
Not applicableUnknownNCT05222633
What this trial is testing

Anti-VEGF in Real-world

Who this might be right for
Neovascular Age-related Macular EdemaDiabetic Macular EdemaChoroidal Neovascular Membrane+3 more
Wenbin Wei 1,000
Next Page